Insider Sale: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)
Natera, Inc.'s (NASDAQ:NTRA) Business Is Yet to Catch Up With Its Share Price
It's not a stretch to say that Natera, Inc.'s (NASDAQ:NTRA) price-to-sales (or "P/S") ratio of 11.6x right now seems quite "middle-of-the-road" for companies in the Biotechs industry in the United
These Are the Stocks With the Highest Increase in Short Interest Within Life Sciences and Diagnostics - Baird
Optimistic Outlook for Natera's Growth Potential Based on ALTAIR Trial and MRD Market Opportunity
$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,300 Today
Natera (NASDAQ:NTRA) has outperformed the market over the past 5 years by 19.94% on an annualized basis producing an average annual return of 33.11%. Currently, Natera has a market capitalization of $
Jefferies Maintains Natera(NTRA.US) With Buy Rating, Maintains Target Price $142
Jefferies analyst Tycho Peterson maintains $Natera(NTRA.US)$ with a buy rating, and maintains the target price at $142.According to TipRanks data, the analyst has a success rate of 55.1% and a total a
Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX), Natera (NTRA) and Argenx Se (ARGX)
Natera to Present at the 28th International Conference on Prenatal Diagnosis and Therapy
Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today announced that its latest research and data on prenatal and reproductive genetics will be presented at the 28th
Insider Sale: CEO and President Steven Chapman Sells 37,500 Shares of Natera Inc (NTRA)
Natera(NTRA.US) Officer Sells US$4.05 Million in Common Stock
$Natera(NTRA.US)$ Officer Chapman Steven Leonard sold 37,500 shares of common stock on Jul 1, 2024 at an average price of $108.1015 for a total value of $4.05 million.Source: Announcement What is stat
Natera(NTRA.US) Director Sells US$293.94K in Common Stock
$Natera(NTRA.US)$ Director Sheena Jonathan sold 2,700 shares of common stock on Jul 1, 2024 at an average price of $108.8684 for a total value of $293.94K.Source: Announcement What is statement of cha
Form 144 | Natera(NTRA.US) Officer Proposes to Sell 4.05 Million in Common Stocks
SEC FILLINGS DISCLOSED/ Jul 1, $Natera(NTRA.US)$ Officer STEVEN L CHAPMAN intends to sell 37,500 shares of its common stock on Jul 1, with a total market value of approximately $4.05 million. STEVEN
Morgan Stanley Maintains Natera(NTRA.US) With Buy Rating, Maintains Target Price $125
Morgan Stanley analyst Tejas Savant maintains $Natera(NTRA.US)$ with a buy rating, and maintains the target price at $125.According to TipRanks data, the analyst has a success rate of 39.7% and a tota
Positive Outlook for Natera Inc.: Savant Recommends Buy on Strong Study Design and Market Strategy
Cathie Wood's Top and Bottom Performing ARKK Holdings of H1
Natera's New Cancer Trial to Use Signatera for Personalized Treatment
Natera, Inc. (NASDAQ:NTRA), a global leader in cell-free DNA (cfDNA) and genetic testing, today announced a new gastroesophageal cancer trial, DECIPHER, that will utilize the company's personalized an
Express News | Natera Announces Decipher: A Phase II, Single-Arm Adjuvant Trial in Gastroesophageal Cancer
Natera(NTRA.US) Director Sells US$296.08K in Common Stock
$Natera(NTRA.US)$ Director Sheena Jonathan sold 2,700 shares of common stock on Jun 18, 2024 at an average price of $109.6591 for a total value of $296.08K.Source: Announcement What is statement of ch
$100 Invested In Natera 5 Years Ago Would Be Worth This Much Today
Natera (NASDAQ:NTRA) has outperformed the market over the past 5 years by 19.2% on an annualized basis producing an average annual return of 32.67%. Currently, Natera has a market capitalization of $1
Health Check: How Prudently Does Natera (NASDAQ:NTRA) Use Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of permanent loss is the risk I worry about... and every practical investor I know wor